School of Life Science and Technology, China Pharmaceutical University, 639 Longmian Road, Nanjing, 211198, Jiangsu, China.
Nanjing Neiwa Faith Pharmaceutical Co Ltd., No. 36, Shuanggao Road, Nanjing, 211399, Jiangsu, China.
Arch Microbiol. 2024 Nov 18;206(12):469. doi: 10.1007/s00203-024-04194-y.
Penicillin-binding proteins (PBPs) are the targets of β-lactam antibiotics; however, changes in the affinity of PBPs for beta-lactam antibiotics often affect the susceptibility of bacteria to antibiotics. The purpose of this study was to elucidate the mechanism by which cefditoren, an oral third-generation cephalosporin, binds PBPs. The minimal inhibitory concentration (MIC), bactericidal curves, and inhibition zone comparisons were assessed to evaluate the antibacterial activity of cefditoren. PBP1A and PBP2X proteins from Streptococcus pneumoniae were purified, and their ability to bind to cefditoren was investigated via microscale thermophoresis. The Kd of cefditoren toward PBP1A was 0.005 ± 0.004 µM, which was lower than those of other cephalosporins (cefcapene, cefixime and cefdinir). In contrast, the Kd of cefditoren toward PBP2X of S. pneumoniae was 9.70 ± 8.24 µM, which was lower than that of cefixime but higher than those of cefcapene and cefdinir. Additionally, the biotinylated ampicillin (BIO-AMP) method was employed to evaluate the affinity of cefditoren toward PBPs of Haemophilus influenzae, and the results demonstrated that cefditoren and PBP3A/B had the lowest IC values (0.060 ± 0.002 µM). These findings indicate that cefditoren has a strong affinity for PBP1A of H. influenzae. Cefditoren has a high affinity toward the PBP1As of S. pneumoniae and PBP1A and PBP3A/B of H. influenzae, which may contribute to the effective antibacterial effects of cefditoren against clinical strains and its low propensity for inducing resistance. The data presented in this article help elucidate the mechanism by which cefditoren, an oral third-generation cephalosporin, binds to PBPs and provide theoretical support for the wider use of cefditoren as an antibiotic therapy.
青霉素结合蛋白(PBPs)是β-内酰胺类抗生素的作用靶点;然而,PBPs 对β-内酰胺类抗生素亲和力的变化常常影响细菌对抗生素的敏感性。本研究旨在阐明口服第三代头孢菌素头孢地尼与 PBPs 结合的机制。通过评估最小抑菌浓度(MIC)、杀菌曲线和抑菌圈比较来评估头孢地尼的抗菌活性。纯化肺炎链球菌的 PBP1A 和 PBP2X 蛋白,并通过微量热泳动研究它们与头孢地尼的结合能力。头孢地尼与 PBP1A 的 Kd 值为 0.005±0.004µM,低于其他头孢菌素(头孢卡品、头孢克肟和头孢地尼)。相比之下,头孢地尼与肺炎链球菌 PBP2X 的 Kd 值为 9.70±8.24µM,低于头孢克肟但高于头孢卡品和头孢地尼。此外,采用生物素化氨苄西林(BIO-AMP)法评估头孢地尼与流感嗜血杆菌 PBPs 的亲和力,结果表明头孢地尼与 PBP3A/B 的 IC 值最低(0.060±0.002µM)。这些发现表明头孢地尼与流感嗜血杆菌的 PBP3A/B 具有很强的亲和力。头孢地尼与肺炎链球菌的 PBP1A 和 PBP1A 和 PBP3A/B 具有高亲和力,这可能有助于头孢地尼对临床分离株的有效抗菌作用及其对诱导耐药性的低倾向。本文提供的资料有助于阐明口服第三代头孢菌素头孢地尼与 PBPs 结合的机制,并为头孢地尼作为抗生素治疗的更广泛应用提供理论支持。